• Mashup Score: 7

    ∗Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands. E-mail: E-mail Address: [email protected] Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Published online March 8,

    Tweet Tweets with this article
    • ICYMI: LA booster strain predicts new onset #AFib in dilated #cardiomyopathy, independent of other parameters such as #LAVI. #Echofirst #LAstrain may serve as an early marker for incident AF. https://t.co/1DMnxM3b2j #JACCIMG #cvImaging #CardioTwitter @RNijveldt @raafs_anne https://t.co/Ta1XY7uK07

  • Mashup Score: 1

    This randomized clinical trial evaluates the efficacy of sacubitril/valsartan vs valsartan in the treatment of left ventricular diastolic function in patients with pre–heart failure with preserved ejection fraction.

    Tweet Tweets with this article
    • The #PARABLE Trial : Effect of Sac/Val vs #Valsartan on LA Volume in Patients With Pre–#HFpEF 👥- 250 Age - 72.0 yr Women - 38.4% HTN - 98% T2DM-24% #Sac/#Val ; ⬆️Maximal #LAVI (6.9 mL/m2; 95% CI, 0.0 to 13.7) ⬇️ Δ pulse pressure (−4.2 mm Hg; 95% https://t.co/C4wCYS2YSK… https://t.co/FFdBLZAg2j https://t.co/MuHadJkUH4